Clinical Trial Update: Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome [Phase 1]

View source ↗

Summary

Phase 1 safety and feasibility study of umbilical cord blood cells in infants with Hypoplastic Left Heart Syndrome; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoplastic Left Heart Syndrome

Drugs mentioned

• Umbilical Cord Blood Cells

Snippet

Sponsor: Michael Cotten | Conditions: Hypoplastic Left Heart Syndrome | Phase 1 | Status: TERMINATED